Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
暂无分享,去创建一个
R. M. Hendry | D. Katzenstein | J. Phair | S. Zeger | L. Sawyer | C. Rinaldo | A. Saah | L. Vujcic | E. Boone | C. C. Williams
[1] M. Reitz,et al. Envelope sequences of two new United States HIV-1 isolates. , 1988, Virology.
[2] B. Moss,et al. Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus. , 1988, The Journal of infectious diseases.
[3] R. M. Hendry,et al. Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus. , 1988, The Journal of infectious diseases.
[4] D. Tyler,et al. CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS , 1988, The Lancet.
[5] B. Walker,et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. , 1988, Science.
[6] D. Shepp,et al. Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens. , 1988, AIDS.
[7] R. Schooley,et al. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus. , 1987, The Journal of infectious diseases.
[8] E. Fenyö,et al. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. , 1987, Journal of immunology.
[9] D. Heitjan,et al. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. , 1987, Journal of immunology.
[10] J. Phair,et al. Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study. , 1987, Annals of internal medicine.
[11] L. Kingsley,et al. 1986 update of HIV seroprevalence, seroconversion, AIDS incidence, and immunologic correlates of HIV infection in patients with hemophilia A and B , 1987 .
[12] J. Phair,et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.
[13] S. Zolla-Pazner,et al. Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Rubinstein,et al. Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus. , 1987, The Journal of infectious diseases.
[15] H. Jaffe,et al. Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression. , 1987, The Journal of clinical investigation.
[16] M. Grieco,et al. Lymphoproliferative responses to human immunodeficiency virus antigen in asymptomatic intravenous drug abusers and in patients with lymphadenopathy or AIDS. , 1987, The Journal of infectious diseases.
[17] B. Autran,et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.
[18] B. Walker,et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.
[19] K. Steimer,et al. Antibody to human immunodeficiency virus correlates with decreased T helper lymphocytes in asymptomatic individuals , 1987, Journal of medical virology.
[20] R. Kurth,et al. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection , 1987, Journal of virology.
[21] D. Cooper,et al. Antibody response to human immunodeficiency virus after primary infection. , 1987, The Journal of infectious diseases.
[22] P. Grob,et al. Anti-HIV IgM antibody analysis during early manifestations of HIV infections. , 1987, AIDS.
[23] A. Fauci,et al. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. , 1987, Journal of immunology.
[24] J. Parker,et al. Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency Syndrome , 1987, Cancer.
[25] J. Phair,et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. , 1987, The New England journal of medicine.
[26] H. Lyerly,et al. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. , 1987, AIDS research and human retroviruses.
[27] A. Dalgleish,et al. Variable and conserved neutralization antigens of human immunodeficiency virus , 1986, Nature.
[28] Hans Wolf,et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS , 1986, Cell.
[29] S. Rasheed,et al. Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. , 1986, Virology.
[30] J. Goedert,et al. Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. , 1986, Annals of internal medicine.
[31] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[32] B. Moss,et al. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques , 1985, Molecular and cellular biology.
[33] R. Detels,et al. IMMUNOLOGICAL CHANGES IN LYMPHADENOPATHY VIRUS POSITIVE AND NEGATIVE SYMPTOMLESS MALE HOMOSEXUALS: TWO YEARS OF OBSERVATION , 1985, The Lancet.
[34] E. Gelmann,et al. Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome. , 1985, The Journal of infectious diseases.
[35] M. Robert-Guroff,et al. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex , 1985, Nature.
[36] W. Darrow,et al. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men. , 1985, Annals of internal medicine.
[37] M. Hirsch,et al. Antibody to lymphadenopathy-associated virus in AIDS. , 1985, The New England journal of medicine.
[38] D. Longo,et al. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. , 1985, The American journal of medicine.
[39] C. Griscelli,et al. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. , 1984, Science.
[40] J. Mouradian,et al. Generalized lymphadenopathy in homosexual men. , 1983, Annals of internal medicine.